InvestorsHub Logo

arvitar

06/26/17 10:34 AM

#133642 RE: KMBJN #133641

Four years ago it was:

- nine "products" being tested in animal models,

- Two candidates to enter human testing within the year.

- "Every big pharma" on planet Earth waiting to propose licensing deals.

http://www.biopharma-reporter.com/Upstream-Processing/NanoViricides-Builds-Plant-to-Prep-for-Viral-Penicillin-Pipeline



Today it is:

- Repeating "skin patch" studies.

- Meeting abstract on cell culture studies. (How exciting!!! LOL!!!)

- No identified lead.

- enough money to keep current operations running for another 13 months.


Seymour's pattern for the past 12.5 years continues.

drkazmd65

06/26/17 11:40 AM

#133649 RE: KMBJN #133641

Agreed - it does look to be well done, sufficiently replicated, and well presented.

It makes me more interested in seeing how these two lead compounds fare in the SUNY lab testing on Dr. Moffat's model.